China Resources Pharmaceutical Group Ltd.(HK:3320)
HK$4.49+0.10 (+2.16%)
HK:3320
China Resources Pharmaceutical Group Ltd. financials statements
HK$4.49
At close:+0.10 (+2.16%)
Want to see HK:3320 full AI Analyst Report?
China Resources Pharmaceutical Group Ltd. (3320) Income Statement
4 Followers
China Resources Pharmaceutical Group Ltd. Income Statement
Last quarter (Q2 2026), China Resources Pharmaceutical Group Ltd.'s total revenue was ¥153.28B, an increase of 9.99% from the same quarter last year. In Q2, China Resources Pharmaceutical Group Ltd.'s net income was ¥2.49B. See China Resources Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 300.01B | ¥ 274.18B | ¥ 270.40B | ¥ 223.13B | ¥ 193.24B | |
| ¥ 49.53B | ¥ 43.30B | ¥ 42.43B | ¥ 34.36B | ¥ 28.87B | |
| ¥ 35.63B | ¥ 30.73B | ¥ 30.52B | ¥ 24.87B | ¥ 21.32B | |
| Depreciation and Amortization | ¥ 4.47B | ¥ 3.61B | ¥ 3.42B | ¥ 2.77B | ¥ 2.35B |
| ¥ 18.55B | ¥ 16.36B | ¥ 15.34B | ¥ 13.59B | ¥ 9.79B | |
| ¥ 13.90B | ¥ 12.56B | ¥ 13.90B | ¥ 9.49B | ¥ 7.55B | |
| ¥ -774.39M | ¥ -931.88M | ¥ -2.97B | ¥ -840.13M | ¥ -685.79M | |
| ¥ 13.13B | ¥ 11.63B | ¥ 10.94B | ¥ 8.65B | ¥ 6.86B | |
| ¥ 4.50B | ¥ 3.57B | ¥ 4.24B | ¥ 3.64B | ¥ 3.08B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.72 | ¥ 0.56 | ¥ 0.68 | ¥ 0.55 | ¥ 0.49 |
| Diluted EPS | ¥ 0.72 | ¥ 0.56 | ¥ 0.68 | ¥ 0.55 | ¥ 0.49 |
| Weighted Average Shares Outstanding | 6.28B | 6.28B | 6.28B | 6.28B | 6.28B |
| Weighted Average Shares Outstanding (Diluted) | 6.28B | 6.28B | 6.28B | 6.28B | 6.28B |
Currency in CNY

